These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 6768646

  • 1. Treatment of non Hodgkin's lymphoma with "PROVECIP" (procarbazine, vinblastine, cyclophosphamide and prednisone).
    Mandelli F, Biagini C, Baroni CD, Bosman C, Anselmo AP, de Luca AM, Granati L, Petti N, Papa G.
    Haematologica; 1980 Feb; 65(1):107-18. PubMed ID: 6768646
    [No Abstract] [Full Text] [Related]

  • 2. Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisone.
    Gibbs GE, Peterson BA, Kennedy BJ, Vosika G, Bloomfield CD.
    Arch Intern Med; 1981 Jun; 141(7):897-900. PubMed ID: 7235809
    [Abstract] [Full Text] [Related]

  • 3. [Comparative study of two drug combination in non-Hodgkin's lymphoma (author's transl)].
    Somoza N, Morgenfeld MC, Magnasco J, Pavlovsky S, Cavagnaro FJ, Saslavsky J, de Maria H, Macchi A, Suárez A.
    Sangre (Barc); 1978 Jun; 23(4):418-25. PubMed ID: 705564
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
    Morgenfeld MC, Pavlovsky A, Suarez A, Somoza N, Pavlovsky S, Palau M, Barros CA.
    Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease.
    Diggs CH, Wiernik PH, Levi JA, Kvols LK.
    Cancer; 1977 May; 39(5):1949-54. PubMed ID: 870162
    [Abstract] [Full Text] [Related]

  • 13. Combination chemotherapy with cyclophosphamide, vinblastine, procarbazine and prednisone in the treatment of malignant lymphomas.
    Host H, Abrahamsen AF.
    Scand J Haematol; 1973 May; 10(3):170-6. PubMed ID: 4588616
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Childhood Hodgkin disease treated with COPP/ABV hybrid chemotherapy: a progress report.
    Sagar TG, Chandra A, Raman SG.
    Med Pediatr Oncol; 2003 Jan; 40(1):66-9. PubMed ID: 12426693
    [No Abstract] [Full Text] [Related]

  • 16. [The role of vinblastine in the treatment of malignant lymphomas].
    Eridani S, Esposito R, Ponti GB, Giangrande A.
    Cancro; 1968 Jan; 21():Suppl 6:102+. PubMed ID: 4906143
    [No Abstract] [Full Text] [Related]

  • 17. Combination therapy with cyclophosphamide, vincristine, procarbazine and prednisone in Hodgkin's disease and reticulum cell sarcoma.
    Isola LM, Cremerius de Sica SM, Palau M, Pereyra MA, Alzugaray AE.
    Medicina (B Aires); 1971 Jan; 31(2):93-7. PubMed ID: 4935790
    [No Abstract] [Full Text] [Related]

  • 18. Long-term follow-up of two chemotherapy protocols in Hodgkin's disease.
    Pavlovsky S, Morgenfeld M, Somoza N, Magnasco J, Sackmann Muriel F, Cavagnaro F, Suárez A, Barros CA, Saslavsky J, Garay G, Palau M, Besuschio SC.
    Medicina (B Aires); 1981 Jan; 41 Suppl():15-21. PubMed ID: 6896551
    [No Abstract] [Full Text] [Related]

  • 19. ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
    Federico M, Luminari S, Iannitto E, Polimeno G, Marcheselli L, Montanini A, La Sala A, Merli F, Stelitano C, Pozzi S, Scalone R, Di Renzo N, Musto P, Baldini L, Cervetti G, Angrilli F, Mazza P, Brugiatelli M, Gobbi PG, HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
    J Clin Oncol; 2009 Feb 10; 27(5):805-11. PubMed ID: 19124807
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.